Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Mark A. Beilke"'
Publikováno v:
American Journal of Health-System Pharmacy. 72:S150-S155
Objective Prolonged oral antimicrobial suppression has been suggested as an alternative treatment for patients with prosthetic joint infections who are unable or unwilling to undergo surgical intervention; however, little data exists for utilizing th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58ae3da242dcb655629f5c83df5bf2dc
https://doi.org/10.2146/sp150022
https://doi.org/10.2146/sp150022
Autor:
Christiane M. Hadi, Arie van der Ende, Susan H. Wootton, Lucrecia Salazar, Monir Hossain, Mark A. Beilke, Rodrigo Hasbun, Diederik van de Beek, Merijn W Bijlsma, Matthijs C. Brouwer, Nabil T. Khoury
Publikováno v:
Journal of Infection
Journal of infection, 67(2), 102-110. W.B. Saunders Ltd
Journal of infection, 67(2), 102-110. W.B. Saunders Ltd
Summary Background We aimed to derive and validate a risk score that identifies adults with cerebrospinal fluid (CSF) pleocytosis and a negative CSF Gram stain at low risk for an urgent treatable cause. Methods Patients with CSF pleocytosis and a neg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c396bc3e3a9c96e5111fae5bd379940
https://doi.org/10.1016/j.jinf.2013.04.002
https://doi.org/10.1016/j.jinf.2013.04.002
Publikováno v:
AIDS Research and Human Retroviruses. 29:1061-1067
Patients with HIV-1 and human T-lymphotropic virus type 2 (HTLV-2) coinfections often exhibit a clinical course similar to that seen in HIV-1-infected individuals who are long-term nonprogressors. These findings have been attributed in part to the ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42587a5a9b3014b33f51af300ab9d0ba
https://doi.org/10.1089/aid.2013.0027
https://doi.org/10.1089/aid.2013.0027
Autor:
Mark A. Beilke
Publikováno v:
AIDS Research and Human Retroviruses. 28:139-147
Retroviral coinfections with HIV-1 and HTLV-1 or with HIV-1 and HTLV-2 occur with variable frequencies throughout the world with the highest prevalence in large metropolitan areas in the Americas, Europe, and Africa. The recognition that retroviral c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41b63ddfd2d899d837749a0e26d063ef
https://doi.org/10.1089/aid.2011.0342
https://doi.org/10.1089/aid.2011.0342
Autor:
Elsa L. Winsor, Mark A. Beilke, Scott A. Simpson, Sandra Eloby-Childress, Debasis Mondal, Upal Roy
Publikováno v:
Journal of Medical Virology. 80:494-500
Co-infections with HIV-1 and the human T leukemia virus types 1 and 2 (HTLV-1, HTLV-2) occur frequently, particularly in large metropolitan areas where injection drug use is a shared mode of transmission. Recent evidence suggests that HIV-HTLV co-inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50a4226c3adcbd1ac8c91f3c9566ce71
https://doi.org/10.1002/jmv.21089
https://doi.org/10.1002/jmv.21089
Autor:
Mark A. Beilke, Maria Sirois, Vicki L. Traina Dorge, Azad R. Bhuiyan, Jane M. Walls, Elsa L. Winsor, Ryan P. Fagan, Edward L. Murphy, Patricia Kissinger
Publikováno v:
Clinical Infectious Diseases. 44:1229-1234
Author(s): Beilke, Mark A; Traina-Dorge, Vicki L; Sirois, Maria; Bhuiyan, Azad; Murphy, Edward L; Walls, Jane M; Fagan, Ryan; Winsor, Elsa L; Kissinger, Patricia J | Abstract: BACKGROUND: Human T lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66aae26f48fc7af6a11ae65f6d05e502
https://doi.org/10.1086/513428
https://doi.org/10.1086/513428
Autor:
Maureen Shuh, Mark A. Beilke
Publikováno v:
Microscopy Research and Technique. 68:176-196
Human T-cell leukemia virus type 1 (HTLV-1) was the first human retrovirus to be identified in the early 1980s. The isolation and identification of a related virus, HTLV-2, and the distantly related human immunodeficiency virus (HIV) immediately foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79403478498fd676577c453c2255b7b8
https://doi.org/10.1002/jemt.20231
https://doi.org/10.1002/jemt.20231
Publikováno v:
Clinical Infectious Diseases. 41:e57-e63
Background. Tropical spastic paraparesis/human T leukemia virus type 1 (HTLV-1)—associated myelopathy (TSP/HAM) is rarely reported in the United States. The causative agents of TSP/HAM are HTLV-1 and, possibly, its cosmopolitan variant, human T leu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d49062064597639b3c42d81bbab02981
https://doi.org/10.1086/432890
https://doi.org/10.1086/432890
Autor:
Stephanie M. Benjamin, O'Brien Megan, Katherine P. Theall, Mark A. Beilke, John L. Clayton, Elsa L. Winsor, Patricia Kissinger
Publikováno v:
Clinical Infectious Diseases. 39:256-263
The goal of this study was to investigate clinical outcomes and survival probabilities among persons coinfected with human immunodeficiency virus (HIV) and human T lymphotropic viruses types 1 and 2 (HTLV-I/II). A nonconcurrent cohort study of 1033 H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c871c5f375926225aef564b5677908a1
https://doi.org/10.1086/422146
https://doi.org/10.1086/422146
Autor:
Jon Cook, Charles B. Hicks, Bruce Coon, Richard Hutt, Margaret A. Fischl, David Pearson, Jan Clark, Candida T. Talabucon, Carol L. Brosgart, Joan Dragavon, Laura Ponticello, Janet Devine, Eugene Sun, Melissa Kerkau, Daniel C. Rodrigue, Donna Thee, Jeanne Berg, Mario Guerrero, Lyle Oshita, Jane L. Norris, Judy Aberg, Mark I. Becker, John Fuchs, Pablo Tebas, Guillermo J. Vázquez, Pamposh Kaul, Antoinette Kenton, Phyllis Barnett, Pascal J. de Caprariis, Michael Royal, Michelle Jack, Ann Walawander, Harold A. Kessler, Scott Souza, Sharon Shriver, Genice Hamilton, Susan E. Cohn, Hailong Cheng, John G. Gerber, Monica Millard, Sherree Wright, Linh Ngo, Gildon N. Beall, Debra Ogata-Arakaki, John Mc Neil, David M. Mushatt, Courtney V. Fletcher, Charles van der Horst, Karen Waterman, Ileana Lopez, David Katzenstein, Robert J. Fass, Joseph J. Eron, Edward P. Acosta, Stephen W. Lagakos, Hilda Mendoza, Jim Bruce, Michael F. Para, Sally Snyder, Mary Shoemaker, Mark A. Beilke, Tammy Powell, Margaret Nelson, Juan J.L. Lertora, Liliana Aguinada, Virginia Ramirez, M. Graham Ray, William W. Freimuth, Brenda Greenhill, Beverly Putnam, Aouie Carrera, Mary Albrecht, Michael F. Giordano, Stuart Carr, John M. Leedom, Charlotte Mills, Charles J. Gonzalez, Rebecca Becker, Richard Haubrich, Elizabeth Gimbel, D. Baker, Vivian Yuan, Andrea Weiss, Hongyu Jiang, Cheryl N. Karol, Kim Ingersol, Russell Strada, Paulette Mac Dougall, Carla Pettinelli, Glenna M. Auerback, Alice F. Mercado, Frances Canchola, Chris Helker, Susan A. Fiscus, X. Joan Hu, Janine R. Maenza, Henry S. Sacks, Robert Kalajian, Debbie Slamowitz, Robin Shepard, Margo Heath-Chiozzi, Michael J. Borucki, Ana Martinez, Olivia T. Ortiz, Suzanne Fiorillo, Jorge Santana, Michael S. Saag, Dena Duran, Steve Nowling, Jeff Taylor, Kristine Todd, Robert W. Coombs, Douglas D. Richman, Thomas C. Merigan, Robert Delapenha, Kenneth Wood, Harvey M. Friedman, Joseph Pulvirenti, Don Craven, Timothy W. Schacker, Ronald Swanstrom, Neel French, Judith Feinberg, Mark A. Jacobson, Judith Brown, Joseph Wheat, Ross G. Hewitt, James F. Rooney, Scott A. Smith, Bruce Peel, Doris Shank, Lisa Alexis, Roy M. Gulick, Andrea Christopher Belschner, Linda Meixner
Publikováno v:
The Journal of Infectious Diseases. 186:626-633
The 24-week extension of AIDS Clinical Trials Group Protocol 359, a study of human immunodeficiency virus (HIV)‐infected, indinavir-experienced patients, was designed to study the durability of “salvage” treatment regimens. Patients received sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca3b1c2613fffeb024856928c7b68a2
https://doi.org/10.1086/342681
https://doi.org/10.1086/342681